{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T07:03:38Z","timestamp":1784099018030,"version":"3.55.0"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Non-alcoholic fatty liver disease (NAFLD) is highly prevalent and closely linked to metabolic dysfunction, with progressive liver fibrosis driving adverse outcomes. Conventional obesity metrics such as body mass index (BMI) and waist circumference inadequately capture body-composition imbalance. The skeletal muscle-to-visceral fat area ratio (SVR) integrates muscle reserve and visceral adiposity and may better reflect metabolic risk. However, large-scale evidence on SVR and fibrosis risk in Chinese patients with NAFLD is limited. This study investigated the association between the SVR and liver fibrosis risk in patients with non-alcoholic fatty liver disease (NAFLD).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A cross-sectional study was conducted involving 661 patients with fatty liver from the Health Management Center of Peking Union Medical College Hospital (Xidan Branch) between January 2021 and November 2024. SVR was measured using a body composition analyzer, and the fibrosis-4 index (FIB-4) was calculated. Because the raw FIB-4 score was right-skewed and the residuals from the raw FIB-4 linear model were not normally distributed, log(FIB-4) was used as the continuous outcome. Hierarchical multivariable linear regression was used to analyze the association between SVR and log(FIB-4), and the mediating role of BMI was tested using the bootstrap method.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The raw FIB-4 score was markedly right-skewed (skewness\u202f=\u202f1.440, Shapiro\u2013Wilk\n                      <jats:italic>p<\/jats:italic>\n                      \u202f&amp;lt;\u202f0.001), whereas the distribution of log(FIB-4) was substantially improved after natural logarithmic transformation (skewness\u202f=\u202f\u22120.123, Shapiro\u2013Wilk\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.444). In the unadjusted model, SVR was inversely associated with log(FIB-4) (B\u202f=\u202f\u22120.067, 95% CI \u22120.109 to \u22120.025,\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.002). In the fully adjusted model including BMI, the inverse association between SVR and log(FIB-4) became stronger. Mediation analysis revealed a significant suppression effect of BMI, with a positive indirect effect and a negative direct effect (indirect effect\u202f=\u202f0.041, direct effect\u202f=\u202f\u22120.108). Subgroup analysis showed that the suppression effect was observed in the higher-BMI subgroup and in both men and women, but not in the lower-BMI subgroup.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Higher SVR was associated with lower log(FIB-4) among patients with NAFLD, and BMI appeared to suppress part of this association. These findings suggest that SVR may provide body-composition information beyond BMI in FIB-4-based risk assessment, but longitudinal studies with more precise fibrosis assessment are needed for validation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fpubh.2026.1816286","type":"journal-article","created":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T06:03:57Z","timestamp":1784095437000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Association between the skeletal muscle-to-visceral fat area ratio and liver fibrosis risk in patients with non-alcoholic fatty liver disease: a cross-sectional study"],"prefix":"10.3389","volume":"14","author":[{"given":"Jingru","family":"Liu","sequence":"first","affiliation":[{"name":"School of Health Policy and Management, Chinese Academy of Medical Sciences and Peking Union Medical College","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xitong","family":"Jiao","sequence":"additional","affiliation":[{"name":"School of Health Policy and Management, Chinese Academy of Medical Sciences and Peking Union Medical College","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Liu","sequence":"additional","affiliation":[{"name":"School of Health Policy and Management, Chinese Academy of Medical Sciences and Peking Union Medical College","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anqi","family":"Chen","sequence":"additional","affiliation":[{"name":"School of Health Policy and Management, Chinese Academy of Medical Sciences and Peking Union Medical College","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qixue","family":"Kang","sequence":"additional","affiliation":[{"name":"School of Health Policy and Management, Chinese Academy of Medical Sciences and Peking Union Medical College","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayue","family":"Guo","sequence":"additional","affiliation":[{"name":"School of Health Policy and Management, Chinese Academy of Medical Sciences and Peking Union Medical College","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxing","family":"Wang","sequence":"additional","affiliation":[{"name":"School of Health Policy and Management, Chinese Academy of Medical Sciences and Peking Union Medical College","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanmeng","family":"Qi","sequence":"additional","affiliation":[{"name":"International Medical Service of Peking Union Medical College Hospital (Xidan Branch)","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"You","sequence":"additional","affiliation":[{"name":"School of Health Policy and Management, Chinese Academy of Medical Sciences and Peking Union Medical College","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,15]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"103043","DOI":"10.1016\/j.arcmed.2024.103043","article-title":"Global prevalence of nonalcoholic fatty liver disease: An updated review Meta-analysis comprising a population of 78 million from 38 countries","volume":"55","author":"Amini-Salehi","year":"2024","journal-title":"Arch Med Res"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1001\/jama.2015.5370","article-title":"Nonalcoholic fatty liver disease: a systematic review","volume":"313","author":"Rinella","year":"2015","journal-title":"JAMA"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1056\/NEJMra1503519","article-title":"Cause, pathogenesis, and treatment of nonalcoholic Steatohepatitis","volume":"377","author":"Diehl","year":"2017","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.jhep.2021.05.003","article-title":"The Chinese Society of Hepatology position statement on the redefinition of fatty liver disease","volume":"75","author":"Nan","year":"2021","journal-title":"J Hepatol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"101271","DOI":"10.1016\/j.jhepr.2024.101271","article-title":"Global burden of metabolic dysfunction-associated steatotic liver disease, 2010 to 2021","volume":"7","author":"Feng","year":"2025","journal-title":"JHEP Rep"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.jhep.2023.04.036","article-title":"Changing epidemiology, global trends and implications for outcomes of NAFLD","volume":"79","author":"Wong","year":"2023","journal-title":"J Hepatol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"987","DOI":"10.3350\/cmh.2023.0035","article-title":"Association of Visceral fat Obesity, sarcopenia, and Myosteatosis with non-alcoholic fatty liver disease without obesity","volume":"29","author":"Kim","year":"2023","journal-title":"Clin Mol Hepatol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1332346","DOI":"10.3389\/fpubh.2024.1332346","article-title":"Association between type 2 diabetes mellitus and body composition based on MRI fat fraction mapping","volume":"12","author":"An","year":"2024","journal-title":"Front Public Health"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"130","DOI":"10.5009\/gnl220041","article-title":"Association between Sarcopenic obesity status and nonalcoholic fatty liver disease and fibrosis","volume":"17","author":"Song","year":"2023","journal-title":"Gut and Liver"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.jamda.2019.12.012","article-title":"Asian working group for sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment","volume":"21","author":"Chen","year":"2020","journal-title":"J Am Med Dir Assoc"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/ageing\/afy169","article-title":"Sarcopenia: revised European consensus on definition and diagnosis","volume":"48","author":"Cruz-Jentoft","year":"2019","journal-title":"Age Ageing"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"e072489","DOI":"10.1136\/bmjopen-2023-072489","article-title":"Association of fat-to-muscle ratio with non-alcoholic fatty liver disease: a single-Centre retrospective study","volume":"13","author":"Yan","year":"2023","journal-title":"BMJ Open"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"495","DOI":"10.2147\/DMSO.S185705","article-title":"Progressive reduction in skeletal muscle mass to visceral fat area ratio is associated with a worsening of the hepatic conditions of non-alcoholic fatty liver disease","volume":"12","author":"Shida","year":"2019","journal-title":"Diabetes Metab Syndr Obes"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.1002\/hep4.1975","article-title":"Skeletal muscle mass to visceral fat area ratio as a predictor of NAFLD in lean and overweight men and women with effect modification by sex","volume":"6","author":"Cho","year":"2022","journal-title":"Hepatol Commun"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"494","DOI":"10.3390\/ijms21020494","article-title":"Sarcopenic obesity, insulin resistance, and their implications in cardiovascular and metabolic consequences","volume":"21","author":"Hong","year":"2020","journal-title":"Int J Mol Sci"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.2174\/138161210791208929","article-title":"Adipocytokines in nonalcoholic fatty liver disease: key players regulating steatosis, inflammation and fibrosis","volume":"16","author":"Tilg","year":"2010","journal-title":"Curr Pharm Des"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1016\/j.clnu.2024.07.006","article-title":"The prevalence and effects of sarcopenia in patients with metabolic dysfunction-associated steatotic liver disease (MASLD): a systematic review and meta-analysis","volume":"43","author":"Li","year":"2024","journal-title":"Clin Nutr"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/s41574-025-01197-7","article-title":"Sarcopenia and MASLD: novel insights and the future","volume":"22","author":"Liu","year":"2026","journal-title":"Nat Rev Endocrinol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"2298","DOI":"10.1016\/j.cgh.2022.11.031","article-title":"Risk stratification for Sarcopenic obesity in subjects with nonalcoholic fatty liver disease","volume":"21","author":"Chun","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1053\/j.gastro.2022.06.023","article-title":"AGA clinical practice update: diagnosis and Management of Nonalcoholic Fatty Liver Disease in lean individuals: expert review","volume":"163","author":"Long","year":"2022","journal-title":"Gastroenterology"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s11894-023-00883-8","article-title":"Screening, diagnosis, and staging of non-alcoholic fatty liver disease (NAFLD): application of society guidelines to clinical practice","volume":"25","author":"Ilagan-Ying","year":"2023","journal-title":"Curr Gastroenterol Rep"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.jhep.2021.05.025","article-title":"EASL clinical practice guidelines on non-invasive tests for evaluation of liver disease severity and prognosis - 2021 update","volume":"75","year":"2021","journal-title":"J Hepatol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1097\/HEP.0000000000000323","article-title":"AASLD practice guidance on the clinical assessment and management of nonalcoholic fatty liver disease","volume":"77","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.jhep.2024.04.031","article-title":"EASL\u2013EASD\u2013EASO clinical practice guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)","volume":"81","year":"2024","journal-title":"J Hepatol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.3350\/cmh.2024.0431","article-title":"Epidemiology of metabolic dysfunction-associated steatotic liver disease","volume":"31","author":"Younossi","year":"2024","journal-title":"Clin Mol Hepatol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"955","DOI":"10.14218\/JCTH.2024.00311","article-title":"Guideline for the prevention and treatment of metabolic dysfunction-associated fatty liver disease (version 2024)","volume":"12","author":"Fan","year":"2024","journal-title":"J Clin Transl Hepatol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"e13569","DOI":"10.1111\/1753-0407.13569","article-title":"Association between the skeletal muscle mass to visceral fat area ratio and metabolic dysfunction-associated fatty liver disease: a cross-sectional study of NHANES 2017-2018","volume":"16","author":"Mai","year":"2024","journal-title":"J Diabetes"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1097\/HC9.0000000000000711","article-title":"Skeletal muscle and MASLD: mechanistic and clinical insights","volume":"9","author":"Marjot","year":"2025","journal-title":"Hepatol Commun"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s12072-018-9875-9","article-title":"Myosteatosis and sarcopenia are associated with hepatic encephalopathy in patients with cirrhosis","volume":"12","author":"Bhanji","year":"2018","journal-title":"Hepatol Int"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1007\/s00535-019-01605-6","article-title":"Sarcopenia in cirrhosis: from pathogenesis to interventions","volume":"54","author":"Ebadi","year":"2019","journal-title":"J Gastroenterol"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"1217249","DOI":"10.3389\/fendo.2023.1217249","article-title":"Lean nonalcoholic fatty liver disease and sarcopenia","volume":"14","author":"Chen","year":"2023","journal-title":"Front Endocrinol"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"1490277","DOI":"10.3389\/fnut.2024.1490277","article-title":"Body composition differences in patients with metabolic dysfunction-associated Steatotic liver disease","volume":"11","author":"Bernal-Contreras","year":"2024","journal-title":"Front Nutr"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"10513","DOI":"10.3390\/nu7125548","article-title":"Comparison of abdominal visceral adipose tissue area measured by computed tomography with that estimated by bioelectrical impedance analysis method in Korean subjects","volume":"7","author":"Lee","year":"2015","journal-title":"Nutrients"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"e036335","DOI":"10.1136\/bmjopen-2019-036335","article-title":"Comparison of visceral fat area measured by CT and bioelectrical impedance analysis in Chinese patients with gastric cancer: a cross-sectional study","volume":"10","author":"Gao","year":"2020","journal-title":"BMJ Open"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"101485","DOI":"10.1016\/j.aohep.2024.101485","article-title":"Correspondence: \u201ca multisociety Delphi consensus statement on new fatty liver disease nomenclature.\u201d","volume":"29","author":"Wan","year":"2024","journal-title":"Ann Hepatol"}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2026.1816286\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T06:03:58Z","timestamp":1784095438000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2026.1816286\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,15]]},"references-count":36,"alternative-id":["10.3389\/fpubh.2026.1816286"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2026.1816286","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,15]]},"article-number":"1816286"}}